References
- Brown RH, Al Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
- Rossor M, Kalmar B, Greensmith L, Reilly M. The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry. 2012;83:6–14.
- Alexandrova J, Paulus C, Rudinger-Thirion J, Jossinet F, Frugier M. Elaborate uORF/IRES features control expression and localization of human glycyl-tRNA synthetase. RNA Biol. 2015;12:1301–13.
- Laio Y, Liu Y, Tsai P, Chang C, Huang Y, Soong B, et al. Two novel de novo GARS mutations cause early-onset axonal Charcot Marie Tooth disease. PLoS One. 2015;10:e0133423.
- Antonellis A, Lee-Lin SQ, Wasterlain A, Leo P, Quezado M, Goldfarb LG, et al. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J Neurosci. 2006;26:10397–406.
- Motley WW, Seburn KL, Nawaz MH, Miers KE, Cheng J, Antonellis A, et al. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet. 2011;7:e1002399.
- Marques VD, Barreira AA, Davis MB, Abou-Sleiman PM, Silva WA, Zago MA, et al. Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia? Muscle Nerve. 2006;34:731–9.
- Nishimura AL, Mitne-Neto M, Silva HCA, Richieri-Costa A, Middleton S, Cascio D, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75:822–31.
- Münch C, Rosenbohm A, Sperfeld A-D, Uttner I, Reske S, Krause BJ, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol. 2005;58:777–80.
- Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet. 2002;71:1189–94.
- Nicolas A, Kenna KP, Renton AE, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268–83.